PN9-25928-16031
3 vaccinations
3 coded responses
23 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 456 / OH
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Moderna
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
-
2021-01-11
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tirednessFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — day 7, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tirednessFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
- 2021-01-26
-
2021-01-29
Dose 2 — Moderna
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-04-30
- 2021-07-30
-
2021-11-02
Dose 3 — Moderna
- 2022-01-29
- 2022-05-03
-
2022-11-04
Survey response — 12 months, dose 3MedDRA: Headache, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Headaches · Healthcare visit (other): Office visitMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-11-07
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-01-29 | Moderna | |
| 3 | 2021-11-02 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Lymphadenopathy
Release 1 — day 7, dose 1
Systemic reaction (other): Swollen lymph nodes
Release 12 — 12 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release